Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6539243

CCOC(=O)c1ccc(-c2cn3nc(-c4ccc(-c5ccccc5)cc4)sc3n2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.56
CA12 O43570 5/20 0.53
CA1 P00915 5/20 0.53
CA2 P00918 5/20 0.53
CA9 Q16790 5/20 0.53
RARA P10276 1/20 0.52
RARB P10826 1/20 0.52
RARG P13631 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
KDM4E B2RXH2 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MAPT P10636 4/20 0.47
ALOX15 P16050 2/20 0.47
PKM P14618 1/20 0.47
RECQL P46063 1/20 0.47
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6538546 0.92 MAPT (0.53) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL7323795 0.91 CA12 (0.56) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL7316392 0.88 TP53 (0.47) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL6538606 0.87 TP53 (0.47) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL7325659 0.87 SIRT2 (0.46) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL7324043 0.86 MTOR (0.42) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL7323148 0.86 LMNA (0.48) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL7319226 0.86 MAPT (0.42) TP53CA12CA1CA2CA9
Trifluoroacetic Acid SCHEMBL7317609 0.85 TP53 (0.41) TP53CA12CA1CA2CA9
SCHEMBL7317639 0.85 CA12 (0.51) TP53CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6743776-B2 ANTIFUNGAL, BETA-1,3-GLUCAN SYNTHASE INHIBITOR, PNEUMOCYSTIS CARINII; AMIDATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-01 US disclosed
US-20020193560-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY ASTELLAS PHARMA INC. (JP) 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193560-A1 CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY NGLY1, CHIT1, MANBA TP53 3997/4885CA12 2703/4885CA1 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.